Meeting abstract
https://doi.org/10.26800/LV-145-supl2-CR09
Cardiotoxicity caused by gemcitabine
Yuri Isaakyan
; Department of Oncology, Radiotherapy and Reconstructive Surgery, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Anastasia Fatyanova
Irina Babkova
Yuri Isaakyan
Ilona Sarukhanyan
Abstract
The use of anticancer drugs leads to the development of various adverse effects, particularly cardiovascular complications. Cardiotoxic effects are awaited, using pyrimidine antimetabolites. Gemcitabine, though being a representative of pyrimidine antagonist group,
is considered to have minimal cardiotoxicity. We present the case of a patient with pancreatic cancer and takotsubo syndrome on gemcitabine monotherapy.
Keywords
cardiotoxicity; chemotherapy; gemcitabine
Hrčak ID:
303054
URI
Publication date:
23.4.2023.
Visits: 165 *